Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder

被引:621
作者
Saxena, S
Rauch, SL
机构
[1] Univ Calif Los Angeles, Obsess Compuls Disorder Res Program, Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Sch Med, Los Angeles, CA 90095 USA
[3] Massachusetts Gen Hosp, Dept Psychiat, Psychiat Neuroimaging Res Program, Boston, MA 02114 USA
[4] Massachusetts Gen Hosp, Dept Radiol, Psychiat Neuroimaging Res Program, Boston, MA 02114 USA
[5] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA
关键词
D O I
10.1016/S0193-953X(05)70181-7
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Advances in neuroimaging have led to a greater understanding of the neurobiology of obsessive-compulsive disorder, providing strong evidence that its pathophysiology involves abnormal functioning along specific frontal-subcortical brain circuits. An updated review and analysis of the functional neuroimaging studies, including single photon emission computed tomography, positron emission tomography, magnetic resonance spectroscopy, and functional magnetic resonance imaging, is provided. Also reviewed is the basic science literature on the functional neuroanatomy of corticobasal gangliathalamocortical circuits, and this information is integrated with neuroimaging data in obsessive-compulsive disorder to present a theoretic model of brain mediation of obsessive-compulsive disorder symptoms and response to treatment. Functional neuroimaging studies indicate that obsessive-compulsive disorder symptoms are mediated by hyperactivity in orbitofrontal-subcortical circuits that may be caused by an imbalance of tone between direct and indirect striatopallidal pathways. Serotonergic drugs may ameliorate obsessive-compulsive disorder symptoms by changing the relative balance of tone through the indirect versus direct orbitofrontal-subcortical pathways, with therapy decreasing activity in the overall circuit that exists in the symptomatic state.
引用
收藏
页码:563 / +
页数:25
相关论文
共 100 条
[81]  
ROSENBERG DR, 1998, 3 INT OCD C MAD PORT
[82]   REGIONAL XENON-133 CEREBRAL BLOOD-FLOW AND CEREBRAL TC-99M-HMPAO UPTAKE IN PATIENTS WITH OBSESSIVE-COMPULSIVE DISORDER BEFORE AND DURING TREATMENT [J].
RUBIN, RT ;
ANANTH, J ;
VILLANUEVAMEYER, J ;
TRAJMAR, PG ;
MENA, I .
BIOLOGICAL PSYCHIATRY, 1995, 38 (07) :429-437
[83]  
RUBIN RT, 1992, ARCH GEN PSYCHIAT, V49, P695
[84]  
SAINTCYR JA, 1992, NEUROPSYCHOLOGY MEMO, P188
[85]   OBSESSIONAL SLOWNESS - FUNCTIONAL-STUDIES WITH POSITRON EMISSION TOMOGRAPHY [J].
SAWLE, GV ;
HYMAS, NF ;
LEES, AJ ;
FRACKOWIAK, RSJ .
BRAIN, 1991, 114 :2191-2202
[86]   Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder [J].
Saxena, S ;
Brody, AL ;
Maidment, KM ;
Dunkin, JI ;
Colgan, M ;
Alborzian, S ;
Phelps, ME ;
Baxter, LR .
NEUROPSYCHOPHARMACOLOGY, 1999, 21 (06) :683-693
[87]  
Saxena S, 1998, BRIT J PSYCHIAT, V173, P26
[88]  
Schwartz JM, 1996, ARCH GEN PSYCHIAT, V53, P109
[89]   The subthalamic nucleus and the external pallidum: Two tightly interconnected structures that control the output of the basal ganglia in the monkey [J].
Shink, E ;
Bevan, MD ;
Bolam, JP ;
Smith, Y .
NEUROSCIENCE, 1996, 73 (02) :335-357
[90]  
SIZER AR, 1992, SEROTONIN CNS RECEPT